STOCK TITAN

Bausch Health to Participate in the J.P. Morgan Global Leveraged Finance Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

Bausch Health Companies (NYSE/TSX: BHC) has announced its participation in the 2025 J.P. Morgan Global Leveraged Finance Conference in Miami Beach, Florida. The event is scheduled for Monday, February 24, 2025, at 8:45 a.m. EST.

The company will provide a live audio webcast of the event, which will be accessible through the Investor Relations section of Bausch Health's website. Interested parties can access the webcast at http://ir.bauschhealth.com/events-and-presentations. A replay of the event will be made available on the same investor relations website after the conference.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction 1 Alert

-3.45% News Effect

On the day this news was published, BHC declined 3.45%, reflecting a moderate negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

LAVAL, QC / ACCESS Newswire / February 14, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), today announced that it will participate in the 2025 J.P. Morgan Global Leveraged Finance Conference in Miami Beach, Florida on February 24. A live audio webcast of the event will be accessible on the Investor Relations section of Bausch Health's website.

Details

Date:

Monday, February 24, 2025

Time:

8:45 a.m. U.S. EST

Webcast:

http://ir.bauschhealth.com/events-and-presentations

A replay of the event will be available on the investor relations website following the event.

About Bausch Health

Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) is a global, diversified pharmaceutical company enriching lives through our relentless drive to deliver better health care outcomes. We develop, manufacture and market a range of products primarily in gastroenterology, hepatology, neurology, dermatology, dentistry, aesthetics, international pharmaceuticals and eye health, through our controlling interest in Bausch + Lomb Corporation. Our ambition is to be a globally integrated healthcare company, trusted and valued by patients, HCPs, employees and investors. For more information about Bausch Health, visit www.bauschhealth.com and connect with us on LinkedIn.

Forward-looking Statements

This news release may contain forward-looking statements within the meaning of applicable securities laws, including the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements may generally be identified by the use of the words "will," "anticipates," "hopes," "expects," "intends," "plans," "should," "could," "would," "may," "believes," "subject to" and variations or similar expressions. These statements are neither historical facts nor assurances of future performance, are based upon the current expectations and beliefs of management and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Actual results are subject to other risks and uncertainties that relate more broadly to Bausch Health's overall business, including those more fully described in Bausch Health's most recent annual and quarterly reports and detailed from time to time in Bausch Health's other filings with the U.S. Securities and Exchange Commission and the Canadian Securities Administrators, which factors are incorporated herein by reference. Readers are cautioned not to place undue reliance on any of these forward-looking statements. These forward-looking statements speak only as of the date hereof. The Company undertakes no obligation to update any of these forward-looking statements to reflect events, information or circumstances after the date of this news release or to reflect actual outcomes, unless required by law.

Investor Contact:
Garen Sarafian
ir@bauschhealth.com
(877) 281-6642 (toll free)

Media Contact:
Katie Savastano
corporate.communications@bauschhealth.com
(908) 569-3692

SOURCE: Bausch Health Companies Inc.



View the original press release on ACCESS Newswire

FAQ

When is Bausch Health (BHC) presenting at the 2025 J.P. Morgan Conference?

Bausch Health (BHC) is presenting at the J.P. Morgan Global Leveraged Finance Conference on Monday, February 24, 2025, at 8:45 a.m. EST in Miami Beach, Florida.

How can investors access BHC's J.P. Morgan Conference presentation?

Investors can access the live audio webcast through Bausch Health's Investor Relations website at http://ir.bauschhealth.com/events-and-presentations.

Will there be a replay available of BHC's 2025 J.P. Morgan Conference presentation?

Yes, a replay of the presentation will be available on Bausch Health's investor relations website following the event.

Which stock exchanges is BHC listed on according to the announcement?

Bausch Health Companies (BHC) is listed on both the New York Stock Exchange (NYSE) and Toronto Stock Exchange (TSX).
Bausch Health Companies Inc

NYSE:BHC

BHC Rankings

BHC Latest News

BHC Latest SEC Filings

BHC Stock Data

2.93B
325.23M
10.78%
68.51%
2.23%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
Canada
QUEBEC